Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe

K-Number: K161552 · 2017-02-02

Decision Date2017-02-02
Product CodeNGT
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe is a medical device manufactured by Becton, Dickinson and Company. It received FDA 510(k) clearance on 2017-02-02 under approval number K161552. The device is classified under product code NGT. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe?

0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe is a medical device that received FDA 510(k) clearance on 2017-02-02. It is manufactured by Becton, Dickinson and Company. The 510(k) number is K161552.

When was 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe approved by the FDA?

0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe received FDA 510(k) clearance on 2017-02-02, under approval number K161552.

What company makes 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe?

0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe is manufactured by Becton, Dickinson and Company.

What is the FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe?

The FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe is NGT.

Related Clinical Trials

Other Devices by Becton, Dickinson and Company

View all 100 devices →

Related Devices (Code: NGT)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.